Table 3. Risk groups for Rifampicin resistance amongst Xpert positive cases.

As in Table 2, all significant associations have p < 10⁻⁵, with the exceptions of: Mumbai patients referred by the private sector (p = 0.01) and by NGOs (p = 0.001).

Predictor	Levels	Odds ratio, unadjusted (95% C.I.)	Odds ratio, adjusted (95% C.I.)
Mumbai TU
Sex	Female	1.53 (1.33, 1.76)	1.5 (1.29, 1.74)
	Male	Reference	Reference
HXTB	Previous history	2.86 (2.48, 3.32)	2.85 (2.46, 3.31)
	No previous history	Reference	Reference
Age	Child	1.38 (0.98, 1.93)	1.23 (0.85, 1.76)
	Adult	Reference	Reference
	Elderly	0.65 (0.47, 0.87)	0.65 (0.48, 0.89)
Provider	Private	1.4 (1.06, 1.85)	1.44 (1.07, 1.91)
	Medical College	2.03 (1.74, 2.36)	1.82 (1.56, 2.13)
	NGO	2.54 (1.5, 4.27)	2.41 (1.4, 4.13)
	ART Centre	0.45 (0.07, 1.67)	0.35 (0.05, 1.34)
	Public	Reference	Reference
Other TUs
Sex	Female	1.06 (0.95, 1.19)	1.12 (0.99, 1.26)
	Male	Reference	Reference
HXTB	Previous history	5.49 (4.91, 6.16)	5.6 (4.99, 6.3)
	No previous history	Reference	Reference
Age	Child	0.9 (0.6, 1.3)	0.95 (0.62, 1.4)
	Adult	Reference	Reference
	Elderly	0.49 (0.4, 0.59)	0.54 (0.44, 0.65)
Provider	Private	1.4 (1.02, 1.89)	1.89 (1.36, 2.58)
	Medical College	2.23 (1.96, 2.53)	2.26 (1.96, 2.59)
	NGO	0.61 (0.42, 0.85)	0.93 (0.63, 1.32)
	ART Centre	1.09 (0.65, 1.73)	1.32 (0.78, 2.12)
	Public	Reference	Reference
Area	Tribal & Hilly	1.21 (1.03, 1.42)	1.18 (0.99, 1.39)
	Urban	1.65 (1.47, 1.85)	1.08 (0.95, 1.23)
	Rural	Reference	Reference